1.Tocotrienol regulates osteoclastogenesis in rheumatoid arthritis
Kyoung-Woon KIM ; Bo-Mi KIM ; Ji-Yeon WON ; Hong Ki MIN ; Seoung Joon LEE ; Sang-Heon LEE ; Hae-Rim KIM
The Korean Journal of Internal Medicine 2021;36(Suppl 1):S273-S282
Background/Aims:
The present study aimed to investigate whether tocotrienol regulates interleukin 17 (IL-17)-induced osteoclastogenesis in rheumatoid arthritis (RA).
Methods:
We evaluated the effect of tocotrienol on IL-17-induced receptor activator of nuclear factor kappa B ligand (RANKL) production using RA fibroblast-like synoviocyte (FLS), together with real-time polymerase chain reaction and enzyme-linked immunosorbent assay. Osteoclast differentiation was confirmed after culturing IL-17-treated RA FLS and Th17 cells with tocotrienol and monocytes. We analyzed the suppressive effect of tocotrienol on Th17 cells percentage or Th17-cytokine levels among peripheral blood mononuclear cells using flow cytometry.
Results:
We found that IL-17 stimulated FLS to produce RANKL and tocotrienol decreased this IL-17-induced RANKL production. Tocotrienol decreased the IL-17-induced activation of mammalian target of rapamycin, extracellular signal-regulated kinase, and inhibitor of kappa B-alpha. When monocytes were incubated with IL-17, RANKL, IL-17-treated FLS or Th17 cells, osteoclasts were differentiated and tocotrienol decreased this osteoclast differentiation. Tocotrienol reduced Th17 cell differentiation and the production of IL-17 and sRANKL; however, tocotrienol did not affect Treg cell differentiation.
Conclusions
Tocotrienol inhibited IL-17- activated RANKL production in RA FLS and IL-17-activated osteoclast formation. In addition, tocotrienol reduced Th17 differentiation. Therefore, tocotrienol could be a new therapeutic choice to treat bone destructive processes in RA.
2.Cutaneous Müllerian Cyst on the Ankle: A Case Report
Junghwa YANG ; Sunmin YIM ; Heunjoo LEE ; Won-serk KIM ; Seoung Wan CHAE ; Ga-Young LEE ; Young Jun CHOI
Korean Journal of Dermatology 2020;58(4):265-268
Cutaneous Müllerian cyst (CMC) is a rare benign cystic lesion that typically occurs on the lower extremity of young females shortly after puberty. They have been widely regarded as Müllerian heterotopias due to the morphological similarities of the cyst lining cells to the epithelium of the fallopian tubes. A 16-year-old female presented with a two-year history of a solitary, subcutaneous mass involving the left ankle. She had no specific symptoms associated with the skin lesion. However, the lesion had been growing in size. Histopathological findings revealed cystic structures lined by pseudostratified ciliated cuboidal to columnar cells, accompanying intraluminal papillary projection. The immunohistochemical staining profiles, including positive staining for estrogen and progesterone receptors, were characteristic of the fallopian tube epithelium. After being surgically removed, the lesion was cured without recurrence. Based on her typical presentation and histopathological findings, we present this patient as a case of CMC.
3.Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization
Ji Eun LEE ; Joong-Won PARK ; In Joon LEE ; Bo Hyun KIM ; Seoung Hoon KIM ; Hyun Beom KIM
Journal of Liver Cancer 2020;20(2):154-159
Spontaneous tumor rupture is a serious but rare complication of hepatocellular carcinoma (HCC) and has a low survival rate. Here, we report a case of massive HCC that ruptured and was treated successfully with transarterial chemoembolization (TACE). A 55-year-old man with abdominal pain was diagnosed with a 12-cm-wide ruptured HCC at segment 8. The overall liver function was scored as Child–Pugh A, but the single nodule tumor had ruptured; therefore, TACE treatment was initiated. After the first TACE treatment, residual tumors were found; thus, secondary TACE was performed 5 months later. No new lesions or extrahepatic metastases were found 16 months after the first TACE treatment, so hepatic resection was performed for curative treatment. The postoperative pathology results did not reveal any cancer cells; hence, TACE alone resulted in a cure. We report this case because the cure has been maintained for more than 3 years after resection.
4.Validation of Previous Spirometric Reference Equations and New Equations
Hye Sook CHOI ; Yong Bum PARK ; Hyoung Kyu YOON ; Seong Yong LIM ; Tae Hyung KIM ; Joo Hun PARK ; Won Yeon LEE ; Seoung Ju PARK ; Sei Won LEE ; Woo Jin KIM ; Ki Uk KIM ; Kyeong Cheol SHIN ; Do Jin KIM ; Tae Eun KIM ; Kwang Ha YOO ; Jae Jeong SHIM ; Yong Il HWANG
Journal of Korean Medical Science 2019;34(47):304-
5.Carpal Tunnel Syndrome Caused by Pseudogout
Eugene KIM ; Seoung Wan CHAE ; Hoseok LEE ; Seok Won LEE
The Journal of the Korean Orthopaedic Association 2019;54(4):372-376
Carpal tunnel syndrome (CTS) caused by pseudogout is an uncommon disease. The authors report a 65-year-old female who complained of sudden pain and neurological symptoms on her left hand. Surgical decompression was performed. In the histologic study, a calcium pyrophosphate dihydrate crystal deposit was confirmed. Her pain and neurological symptoms were relieved. Because CTS caused by pseudogout is rare, it is difficult to differentiate it from other diseases. This paper reports an uncommon case of CTS caused by pseudogout.
Aged
;
Calcium Pyrophosphate
;
Carpal Tunnel Syndrome
;
Chondrocalcinosis
;
Decompression, Surgical
;
Female
;
Hand
;
Humans
;
Median Nerve
6.Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea
Chan Sun PARK ; Dong Yoon KANG ; Min Gyu KANG ; Sujeong KIM ; Young Min YE ; Sae Hoon KIM ; Hye Kyung PARK ; Jung Won PARK ; Young Hee NAM ; Min Suk YANG ; Young Koo JEE ; Jae Woo JUNG ; Sang Hyon KIM ; Cheol Woo KIM ; Mi Yeong KIM ; Joo Hee KIM ; Jaechun LEE ; Jun Gyu LEE ; Sang Hyun KIM ; Hyen O LA ; Min Hye KIM ; Seoung Ju PARK ; Young Il KOH ; Sang Min LEE ; Yong Eun KWON ; Hyun Jung JIN ; Hee Kyoo KIM ; Hye Ryun KANG ; Jeong Hee CHOI ;
Allergy, Asthma & Immunology Research 2019;11(5):709-722
PURPOSE: Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS) to antiepileptic drug (AED), are rare, but result in significant morbidity and mortality. We investigated the major culprit drugs, clinical characteristics, and clinical course and outcomes of AED-induced SCARs using a nationwide registry in Korea. METHODS: A total of 161 patients with AED-induced SCARs from 28 referral hospitals were analyzed. The causative AEDs, clinical characteristics, organ involvements, details of treatment, and outcomes were evaluated. We compared the clinical and laboratory parameters between SJS/TEN and DRESS according to the leading causative drugs. We further determined risk factors for prolonged hospitalization in AED-induced SCARs. RESULTS: Carbamazepine and lamotrigine were the most common culprit drugs causing SCARs. Valproic acid and levetiracetam also emerged as the major causative agents. The disease duration and hospital stay in carbamazepine-induced SJS/TEN were shorter than those in other AEDs (P< 0.05, respectively). In younger patients, lamotrigine caused higher incidences of DRESS than other drugs (P= 0.045). Carbamazepine, the most common culprit drug for SCARs, was associated with a favorable outcome related with prolonged hospitalization in SJS (odds ratio, 0.12; 95% confidence interval, 0.02-0.63, P= 0.12), and thrombocytopenia was found to be a risk factor for prolonged hospitalization in DRESS. CONCLUSION: This was the first large-scale epidemiological study of AED-induced SCARs in Korea. Valproic acid and levetiracetam were the significant emerging AEDs causing SCARs in addition to the well-known offending AEDs such as carbamazepine and lamotrigine. Carbamazepine was associated with reduced hospitalization, but thrombocytopenia was a risk factor for prolonged hospitalization. Our results suggest that the clinical characteristics and clinical courses of AED-induced SCARs might vary according to the individual AEDs.
Anticonvulsants
;
Carbamazepine
;
Cicatrix
;
Drug Hypersensitivity Syndrome
;
Epidemiologic Studies
;
Hospitalization
;
Humans
;
Incidence
;
Korea
;
Length of Stay
;
Mortality
;
Referral and Consultation
;
Risk Factors
;
Stevens-Johnson Syndrome
;
Thrombocytopenia
;
Valproic Acid
7.Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011–2018.
Tae Ok KIM ; Hong Joon SHIN ; Yu Il KIM ; Chin Kook RHEE ; Won Yeon LEE ; Seong Yong LIM ; Seung Won RA ; Ki Suck JUNG ; Kwang Ha YOO ; Seoung Ju PARK ; Sung Chul LIM
Chonnam Medical Journal 2019;55(1):47-53
The guidelines for chronic obstructive pulmonary disease (COPD) treatment are important for the management of the disease. However, studies regarding the treatment adherence to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines have been scarce in Korea. Therefore, to examine the adherence to the GOLD guidelines, we examined the patterns of prescribed medication in COPD patients from 2011 to 2018. Patients were classified as having been appropriately and inappropriately treated (overtreatment or undertreatment) for the GOLD group. Appropriate medical therapy was defined as using the first choice or alternative choice drug recommended in the GOLD guidelines. Inappropriate therapy was classified as overtreatment or undertreatment in accordance with the categorization in the GOLD guidelines. According to treatment of 2011 GOLD guidelines, there was inappropriate treatment in 52.3% in group A, 47.3% in group B, 56.3% in group C, and 17.8% in group D. According to treatment of 2017 GOLD guidelines, there was inappropriate treatment in 66.7% in group A, 45.3% in group B, 14.3% in group C, and 24.0% in group D. The common type of inappropriate COPD treatment is overtreatment, with inhaled corticosteroid (ICS) containing regimens. In conclusions, adherence to the GOLD guideline by the pulmonologist in clinical practice is still low in Korea. Therefore, we need better strategies to both optimize the use of the guidelines and adhere to the guidelines as well.
Humans
;
Korea*
;
Lung Diseases
;
Medical Overuse
;
Pulmonary Disease, Chronic Obstructive*
8.The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106).
Boram HA ; Kwan Ho CHO ; Sung Ho MOON ; Chang Geol LEE ; Ki Chang KEUM ; Yeon Sil KIM ; Hong Gyun WU ; Jin Ho KIM ; Yong Chan AHN ; Dongryul OH ; Jae Myoung NOH ; Jong Hoon LEE ; Sung Hwan KIM ; Won Taek KIM ; Young Taek OH ; Min Kyu KANG ; Jin Hee KIM ; Ji Yoon KIM ; Moon June CHO ; Chul Seoung KAY ; Jin Hwa CHOI
Cancer Research and Treatment 2019;51(1):12-23
PURPOSE: The purpose of this study was to investigate the effect of hospital case volume on clinical outcomes in patients with nasopharyngeal carcinoma (NPC). MATERIALS AND METHODS: Data on 1,073 patients with cT1-4N0-3M0 NPC were collected from a multi-institutional retrospective database (KROG 11-06). All patients received definitive radiotherapy (RT) either with three-dimensional-conformal RT (3D-CRT) (n=576) or intensity-modulated RT (IMRT) (n=497). The patients were divided into two groups treated at high volume institution (HVI) (n=750) and low volume institution (LVI) (n=323), defined as patient volume ≥ 10 (median, 13; range, 10 to 18) and < 10 patients per year (median, 3; range, 2 to 6), respectively. Endpoints were overall survival (OS) and loco-regional progression-free survival (LRPFS). RESULTS: At a median follow-up of 56.7 months, the outcomes were significantly better in those treated at HVI than at LVI. For the 614 patients of propensity score-matched cohort, 5-year OS and LRPFS were consistently higher in the HVI group than in the LVI group (OS: 78.4% vs. 62.7%, p < 0.001; LRPFS: 86.2% vs. 65.8%, p < 0.001, respectively). According to RT modality, significant difference in 5-year OS was observed in patients receiving 3D-CRT (78.7% for HVI vs. 58.9% for LVI, p < 0.001) and not in those receiving IMRT (77.3% for HVI vs. 75.5% for LVI, p=0.170). CONCLUSION: A significant relationship was observed between HVI and LVI for the clinical outcomes of patients with NPC. However, the difference in outcome becomes insignificant in the IMRT era, probably due to the standardization of practice by education.
Cohort Studies
;
Disease-Free Survival
;
Education
;
Follow-Up Studies
;
Humans
;
Nasopharyngeal Neoplasms
;
Radiotherapy
;
Radiotherapy, Intensity-Modulated
;
Retrospective Studies*
;
Treatment Outcome
9.Appropriate angle and depth in thoracic transforaminal epidural block in Koreans.
Chan NOH ; Won Hyung LEE ; Young Kwon KO ; Sun Yeul LEE ; Yeo Jung KIM ; Seoung Hun LEE ; Choon Ho JUNG ; Hye Min KANG
Anesthesia and Pain Medicine 2018;13(4):427-434
BACKGROUND: Selective transforaminal epidural block has come to the for as a targetspecific modality in the treatment and diagnosis of spinal pain. Thoracic transforaminal epidural block (TTFEB) has the associated risk of pneumothorax. This article describes a retrospective study conducted using computed tomography (CT) imaging to investigate the TTFEB angle and depth appropriate to minimize the risk of pneumothorax in Koreans. METHODS: The subjects of the present study were 100 randomly selected patients between 50 and 70 years of age found be free of thoracic disease according to chest CT performed in the present hospital. On the chest CT, the superior, middle, and inferior thoracic vertebrae were observed at the T2, T7, and T11 levels, respectively. RESULTS: The average distance and the needle insertion angle from the skin point at which the needle may be inserted without piercing the lung to the intervertebral foramen were 117.8 ± 12.1 mm and 58.1 ± 6.1° at the T2 level, 85.6 ± 10.0 mm and 61.7 ± 4.3° at the T7 level, and 94.3 ± 8.7 mm and 64.4 ± 7.0° at the T11 level, respectively. CONCLUSIONS: The needle insertion at the point further than 40 mm, on the upper, middle thorax, if the needle pass from the inner vertebral body to lamina, it could be safer. However, on the lower thorax, needle could pierce the lung though the needle start from the inner vertebral body. Thus, it can be safer if the needle pass toward the exterior margin of lamina.
Diagnosis
;
Humans
;
Lung
;
Needles
;
Pneumothorax
;
Retrospective Studies
;
Skin
;
Thoracic Diseases
;
Thoracic Vertebrae
;
Thorax
;
Tomography, X-Ray Computed
10.Bacterial infection monitoring in the early period after liver transplantation.
Ji Soo LEE ; Seung Hwan LEE ; Kyeong Sik KIM ; Eun Mi GIL ; Gyu Seoung CHOI ; Jong Man KIM ; Kyong Ran PECK ; Choon Hyuck David KWON ; Jae Won JOH ; Suk Koo LEE
Annals of Surgical Treatment and Research 2018;94(3):154-158
PURPOSE: Infection remains the main cause of morbidity and mortality in liver transplantation (LT) recipients; however infection is notoriously difficult to diagnose because its usual signs and symptoms of infection may be masked or absent. This study comprises an analysis of bacterial infections in the early period after LT. METHODS: This is a study of 129 adults who underwent LT from January 2013 to December 2013, and it includes patients who were followed daily from the day of transplantation to 1-week posttransplantation using bacteriological cultures of blood, urine, sputum, and drained ascites. RESULTS: The following factors were significantly different between the positive and negative culture groups: living donor LT vs. deceased donor LT (odds ratio [OR], 3.269; P = 0.003), model for end-stage liver disease score (OR, 4.364; P < 0.001), and Child-Pugh classification (P = 0.007). Neither positive culture nor negative culture was associated with infection within 4 weeks of surgery (P = 0.03), and most events were due to surgical complications (75%). CONCLUSION: Since the full effect of immunosuppression is not yet present during the first month after LT, we suggest that the number of bacterial culture test could be reduced such that they are performed every other day depending on patient's situation.
Adult
;
Ascites
;
Bacterial Infections*
;
Classification
;
Culture Techniques
;
Humans
;
Immunosuppression
;
Liver Diseases
;
Liver Transplantation*
;
Liver*
;
Living Donors
;
Masks
;
Mortality
;
Sputum
;
Tissue Donors

Result Analysis
Print
Save
E-mail